Key facts
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Vancardio
- ·The full record, as it builds
Funding rounds
No funding rounds for Vancardio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vancardio
Manufacturer of advanced cardiac monitoring technology intended to improve diagnostic accuracy and enhance early disease detection. The company offers three-dimensional electrocardiography, cardiac mapping, ventricular late potential analysis, dynamic heart signal collection, and AI-driven diagnostic models, enabling healthcare providers to achieve precise screening, reduce misdiagnosis, and safeguard patient health.
- Sector
- Healthcare
- HQ
- Jiaxing, China
- Founded
- 2026
- Ownership
- Privately Held (backing)
Vancardio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vancardio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vancardio in its N-PORT filings yet. We sweep new filings monthly.